About the Company
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue. Merck & Co. was originally established as the American affiliate of Merck Group in 1891. Merck develops and produces medicines, vaccines, biologic therapies and animal health products. It has multiple blockbuster drugs or products each with 2020 revenues including cancer immunotherapy, anti-diabetic medication and vaccines against HPV and chickenpox. The company is ranked 71st on the 2022 Fortune 500 and 87th on the 2022 Forbes Global 2000, both based on 2021 revenues. In 2023, the company’s seat in Forbes Global 2000 was 73.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MRK News
Here’s Why Merck & Co. (MRK) Outperformed in Q1
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A ...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company ...
Merck, NCA&T launch biotech learning center
The new Merck Biotechnology Learning Center is designed to foster that kind of STEM workforce success. Sanat Chattopadhyay, ...
Merck gets grant for fast disintegrating tablet with compound of formula ia
Discover how Merck & Co Inc's patented tablet with Formula I compound in a water-soluble polymer matrix offers rapid release & improved bioavailability.
Merck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.
For instance, on April 5, Merck (NYSE: MRK) spent $208 million to acquire a business called Abceutics, which is developing a ...
Merck Introduces Aptegra CHO genetic stability assay for accelerated biosafety testing
Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its ...
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver ...
Patrick Soon-Shiong's ImmunityBio bags FDA approval for Anktiva to challenge Merck in bladder cancer
ImmunityBio has yet to finalize a registrational trial plan with the FDA in that papillary disease population, Soon-Shiong ...
Better Growth Play: Merck or The Vanguard Growth Index Fund?
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Unveiling 17 Analyst Insights On Merck & Co
In the assessment of 12-month price targets, analysts unveil insights for Merck & Co, presenting an average target of $135.35 ...
Health Canada approves Merck’s Keytruda for gastric cancer treatment
Health Canada has approved Merck & Co Inc (MSD)’s Keytruda (pembrolizumab), an anti-programmed cell death protein 1 (PD-1) ...
Merck is buying a UB cancer research startup for as much as $208 million
Global biopharmaceutical company Merck is spending up to $208 million to acquire a cancer research startup spun out of the ...
Loading the latest forecasts...